Clinical Trial : Complications of in the Bag IOL Versus Optic Capture of IOL in Pediatric Cataract Surgery

July 2, 2015 updated by: Abhay R. Vasavada, Iladevi Cataract and IOL Research Center

Visual Axis Obscuration and Postoperative Complications Following Pediatric Cataract Surgery With Introacular Lens Implantation In-the-bag Versus Posterior Optic Capture : A Randomized, Clinical Trial

This prospective, randomized, clinical trial looks to compare children undergoing congenital cataract surgery with intraocular lens (IOL) implantation in terms of visual axis obscuration as well as postoperative complications such as glaucoma, inflammation and IOL centration when IOL fixation is performed using two different techniques : 1) conventional in the bag IOL implantation with anterior vitrectomy, and, 2) posterior optic capture of the IOL through the posterior capsulorhexis without any vitrectomy. 61 eyes of 61 children randomized to receiving IOL implantation using one of the two techniques will be followed up until 12 months postoperatively.

Study Overview

Detailed Description

This prospective, randomized, controlled, clinical trial compares visual axis obscuration as well as intra and postoperative complications in children undergoing cataract surgery with IOL implantation using one of two techniques :

  1. in the bag IOL with limbal anterior vitrectomy
  2. posterior optic capture of IOL optic through the posterior capsulorhexis without any vitrectomy.

The aim is to evaluate whether avoiding anterior vitrectomy is a feasible option, particularly younger children, where anterior vitrectomy has become an integral part of the routine surgical strategy.

All children will be evaluated at 1 month, 3 months, 6 months and 12 months postoperatively.

Study Type

Interventional

Enrollment (Actual)

61

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

2 weeks to 4 years (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • uncomplicated cataract,
  • unilateral or bilateral cataract,
  • corneal diameter >9.0mmHg

Exclusion Criteria:

  • pre-existing glaucoma,
  • uveitis,
  • ocular comorbidity,
  • microphthalmos,
  • microcornea,
  • parents not consenting to participate in study,
  • traumatic cataract

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: In the bag IOL
Cataract surgery with IOL implantation in the capsular bag
cataract surgery in children
intraocular lens implantation in the capsular bag or optic capture
Active Comparator: Optic Capture of IOL
intraocular lens implantation in the capsular bag with posterior optic capture
cataract surgery in children
intraocular lens implantation in the capsular bag or optic capture

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Posterior capsule opacification requiring surgery
Time Frame: 12 months postoperatively
opacification of visual axis
12 months postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
inflammation on slitlamp examination
Time Frame: 12 months postoperatively
cell depostis
12 months postoperatively
inflammation on slitlamp examination
Time Frame: 12 months postoperatively
posterior synechiae
12 months postoperatively
intraocular pressure in mmHg
Time Frame: 12 months postoperatively
glaucoma
12 months postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: abhay vasavada, MS,FRCS, Iladevi Cataract & IOL Research Centre, Ahmedabad, India

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2013

Primary Completion (Actual)

April 1, 2015

Study Completion (Actual)

April 1, 2015

Study Registration Dates

First Submitted

June 29, 2015

First Submitted That Met QC Criteria

July 2, 2015

First Posted (Estimate)

July 8, 2015

Study Record Updates

Last Update Posted (Estimate)

July 8, 2015

Last Update Submitted That Met QC Criteria

July 2, 2015

Last Verified

July 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • 13-009
  • 2013 Research Foundation Grant (Other Grant/Funding Number: ASCRS Foundation Research Grant)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Complications

Clinical Trials on cataract surgery

Subscribe